Steven Wheen's Stock Coverage
| RMDResmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh | Nov 02, 2026 | BUY | Reiterated | AU$38.70 | 24Ratings | +7.17% | ||
| IDXIntegral Diagnostics Ltd. | Oct 30, 2026 | HOLD | Downgraded | AU$2.35 | 25Ratings | -15.04% | ||
| HLSHealius Limited | Oct 23, 2026 | HOLD | Reiterated | AU$0.51 | 35Ratings | +24.39% | ||
| TLXTelix Pharmaceuticals | Oct 21, 2026 | BUY | Reiterated | AU$21.00 | 34Ratings | +38.67% | ||
| REGRegis Healthcare Ltd. | Sep 03, 2026 | HOLD | Reiterated | AU$6.20 | 18Ratings | +8.32% | ||
| RHCRamsay Health Care | Aug 28, 2026 | BUY | Reiterated | AU$53.00 | 29Ratings | -2.32% | ||
| SHLSonic Healthcare Limited | Aug 21, 2026 | HOLD | Reiterated | AU$22.90 | 30Ratings | ― | ― | |
| CSLCSL | Aug 19, 2026 | BUY | Upgraded | AU$207.00 | 34Ratings | -19.37% | ||
| COHCochlear | Aug 19, 2026 | HOLD | Reiterated | AU$165.00 | 17Ratings | +2.67% | ||
| QBEQBE Insurance Group Limited | Feb 20, 2026 | HOLD | Reiterated | AU$22.00 | 1Ratings | ― | ― |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Steven Wheen activity FAQ
What is the performance of Steven Wheen's recommendations?
The percentage of profitable recommendations made by Steven Wheen is 46.72%, and the average return per transaction is 8.00%.
What stocks does Steven Wheen cover?
Steven Wheen mostly covers Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, Integral Diagnostics Ltd., Healius Limited stocks.
What was Steven Wheen's most profitable rating?
Steven Wheen’s most profitable rating was a buy on Telix Pharmaceuticals stock on Feb 23, 2024. The return on the trade was 174.70%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here